Literature DB >> 17868741

Bacillus Calmette-Guerin mechanism of action: the role of immunity, apoptosis, necrosis and autophagy.

Robert S DiPaola, Edmund C Lattime.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17868741     DOI: 10.1016/j.juro.2007.08.063

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  8 in total

1.  Enhanced antitumor effect of combination intravesical mitomycin C and bacillus Calmette-Guerin therapy in an orthotopic bladder cancer model.

Authors:  Masashi Matsushima; Minoru Horinaga; Ryuichi Fukuyama; Hitoshi Yanaihara; Eiji Kikuchi; Makoto Kawachi; Masahiro Iida; Yoko Nakahira; Mototsugu Oya; Hirotaka Asakura
Journal:  Oncol Lett       Date:  2010-11-23       Impact factor: 2.967

2.  Alterations in ubiquitin ligase Siah-2 and its corepressor N-CoR after P-MAPA immunotherapy and anti-androgen therapy: new therapeutic opportunities for non-muscle invasive bladder cancer.

Authors:  Patrick Vianna Garcia; Letícia Montanholi Apolinário; Petra Karla Böckelmann; Iseu da Silva Nunes; Nelson Duran; Wagner José Fávaro
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

3.  Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8.

Authors:  A Q Sukkurwala; I Martins; Y Wang; F Schlemmer; C Ruckenstuhl; M Durchschlag; M Michaud; L Senovilla; A Sistigu; Y Ma; E Vacchelli; E Sulpice; X Gidrol; L Zitvogel; F Madeo; L Galluzzi; O Kepp; G Kroemer
Journal:  Cell Death Differ       Date:  2013-06-21       Impact factor: 15.828

4.  Effects of P-MAPA Immunomodulator on Toll-Like Receptors and p53: Potential Therapeutic Strategies for Infectious Diseases and Cancer.

Authors:  Wagner J Fávaro; Odilon S Nunes; Fabio Rf Seiva; Iseu S Nunes; Lisa K Woolhiser; Nelson Durán; Anne J Lenaerts
Journal:  Infect Agent Cancer       Date:  2012-06-18       Impact factor: 2.965

5.  Bacillus Calmette-Guerin therapy after the second transurethral resection significantly decreases recurrence in patients with new onset high-grade T1 bladder cancer.

Authors:  Keitaro Iida; Taku Naiki; Noriyasu Kawai; Toshiki Etani; Ryosuke Ando; Yosuke Ikegami; Takehiko Okamura; Hiroki Kubota; Atsushi Okada; Kenjiro Kohri; Takahiro Yasui
Journal:  BMC Urol       Date:  2016-02-27       Impact factor: 2.264

Review 6.  Predictive Markers for the Recurrence of Nonmuscle Invasive Bladder Cancer Treated with Intravesical Therapy.

Authors:  Yasuyoshi Miyata; Hideki Sakai
Journal:  Dis Markers       Date:  2015-11-23       Impact factor: 3.434

7.  Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier.

Authors:  Patrick Vianna Garcia; Fábio Rodrigues Ferreira Seiva; Amanda Pocol Carniato; Wilson de Mello Júnior; Nelson Duran; Alda Maria Macedo; Alexandre Gabarra de Oliveira; Rok Romih; Iseu da Silva Nunes; Odilon da Silva Nunes; Wagner José Fávaro
Journal:  BMC Cancer       Date:  2016-07-07       Impact factor: 4.430

8.  Growth inhibition of HeLa cell by internalization of Mycobacterium bovis Bacillus Calmette-Guérin (BCG) Tokyo.

Authors:  Akira Kitamura; Sohkichi Mastumoto; Izumi Asahina
Journal:  Cancer Cell Int       Date:  2009-12-02       Impact factor: 5.722

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.